Elevance Health, Inc. ELV
What this company does
Written from the business description in Elevance Health, Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 6 February 2026. Every sentence was checked against that document before publication.
Revenue compounded at +10.3% a year over five years — but profit grew slower: net income at +4.4%, earnings per share at +7.0%.
The share count fell from 0.25B to 0.22B — the buyback concentrates the same profit into fewer slices.
Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.
Each USD of equity produced 13 cents of profit this year.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue $B | 199.1 | 177.0 | 171.3 | 156.6 | 138.6 | 121.9 | 104.2 | 92.1 | 90.0 | 84.9 | 79.2 | 73.9 | 71.0 | 61.5 | 60.7 | 58.7 | 64.9 | 61.3 | 61.2 |
| Operating income $B | 7.2 | 7.9 | 8.5 | 8.3 | 7.6 | 6.4 | 6.0 | 5.4 | 4.2 | 4.8 | 4.8 | 4.4 | 4.0 | 3.6 | 3.8 | 4.1 | 4.2 | 4.3 | · |
| EBITDA $B | 8.7 | 9.3 | 10.2 | 10.0 | 8.9 | 7.5 | 7.1 | 6.6 | 4.3 | 4.9 | 4.9 | 4.5 | 4.1 | 3.7 | 3.9 | 4.2 | 4.3 | 4.5 | · |
| Income tax $B | 1.0 | 1.9 | 1.7 | 1.7 | 1.8 | 1.7 | 1.2 | 1.3 | 0.1 | 2.1 | 2.1 | 1.8 | 1.2 | 1.2 | 1.3 | 1.5 | 2.7 | 0.6 | 1.9 |
| Net income $B | 5.7 | 6.0 | 6.0 | 5.9 | 6.2 | 4.6 | 4.8 | 3.8 | 3.8 | 2.5 | 2.6 | 2.6 | 2.5 | 2.7 | 2.6 | 2.9 | 4.7 | 2.5 | 3.3 |
| Free cash flow $B | 3.2 | 4.6 | 6.8 | 7.2 | 7.3 | 9.7 | 5.0 | 2.6 | 3.4 | 2.7 | 3.6 | 2.7 | 2.4 | 2.2 | 2.9 | 1.0 | 2.7 | 2.2 | 4.0 |
| EPS, diluted $ | 25.21 | 25.68 | 25.22 | 24.28 | 24.95 | 17.98 | 18.47 | 14.19 | 14.35 | 9.21 | 9.38 | 8.99 | 8.20 | 8.18 | 7.25 | 6.94 | 9.88 | 4.76 | 5.56 |
| Dividend / sh $ | · | · | 5.92 | 5.12 | 4.52 | 3.80 | 3.20 | 3.00 | 2.70 | 2.60 | 2.50 | 1.75 | 1.50 | 1.15 | 1.00 | 0.00 | · | · | · |
| Payout % | 27 | 25 | 23 | 21 | 18 | 21 | 17 | 21 | 18 | 28 | 26 | 19 | 18 | 14 | 14 | 0 | · | · | · |
| ROE % | 13.3 | 14.8 | 15.8 | 16.3 | 17.8 | 14.1 | 16.0 | 13.6 | 14.9 | 10.3 | 10.8 | 10.5 | 10.3 | 11.3 | 11.2 | 11.9 | 20.5 | 11.2 | 14.6 |
| Shares out B | 0.22 | 0.23 | 0.23 | 0.24 | 0.24 | 0.25 | 0.25 | 0.26 | 0.26 | 0.26 | 0.26 | 0.27 | 0.29 | 0.30 | 0.34 | 0.38 | 0.45 | 0.50 | · |
Slide the table for earlier years · "·" marks a figure not available in our data for that year.
This company against its peers
Reconciled in 19 of 19 fiscal years. 7 checks could not be computed.